Xenocor, a Salt Lake City-based developer of a laparoscopic imaging system, has named Mark Foster to its board of directors. Foster has 20 years of general management and leadership experience from both venture-backed growth-stage organizations and medical device companies. He currently is CEO of Trice Medical, a venture-backed company that offers products for minimally invasive diagnostic and therapeutic orthopedic procedures. His experience also includes senior management positions focused on business development to include fundraising, licensing, M&A, commercialization and supply chain initiatives at Smith and Nephew and Boston Scientific.
Position
To board of directors
